Some patient advocates from the NCCN Guidelines Panels who make evidence-based expert consensus-driven recommendations for cancer prevention, treatment, and supportive care are sharing their unique stories in honor of this year鈥檚 World Cancer Day.
NCCN鈥攁n alliance of leading cancer centers鈥攑ublishes a new resource to inform people about the latest recommendations around hereditary and familial cancer risk.
A meeting at the Middle East North Africa (MENA)-NCCN Regional Coordinating Center聽presents new and updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines庐): MENA Editions, and selected topics highlighting cancer advances, challenges, and opportunities in the region.
The NCCN Oncology Research Program (ORP) announces funding of a project that will underpin innovative research on optimal management of side effects secondary to treatment with poly ADP ribose polymerase inhibitors (PARPi).
NCCN hosts a Patient Advocacy Summit bringing together leading experts to promote strategies and best practices for improving cancer care, focused on practice and policy solutions for sharing accurate, evidence-based health information with patients and caregivers.
The NCCN Oncology Research Program (ORP) announces the awarding of new quality improvement research grants aimed at advancing care for patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
The National Comprehensive Cancer Network (NCCN) is honored to participate in 2024 CCHIO. NCCN has taken numerous strides in recent years to increase the global accessibility and relevance of NCCN Guidelines as a tool for helping people with cancer to live better lives, including multiple collaborations with leading oncology groups in China.
Newly-published NCCN Guidelines for Patients: Quitting Smoking explains what the evidence and expert consensus is on how to best use the tools that exist to help anyone quit for good.
NCCN expands guidelines to create two major resources for helping cancer care providers and other stakeholders stay current on cutting edge research on genetic/familial high-risk assessment.
Leaders from the National Comprehensive Cancer Network (NCCN) travel to Vietnam to collaborate with Vietnam National Cancer Hospital on improving cancer care standards throughout the country.
International oncology experts gather in Accra, Ghana for a series of meetings to update cancer treatment recommendations in the NCCN Harmonized Guidelines鈩� for Sub-Saharan Africa.
National Comprehensive Cancer Network (NCCN) presents preliminary data from a study demonstrating the usability of the Health Equity Report Card (HERC) tool during the American Public Health Association (APHA) Annual Meeting and Expo.
New study in JNCCN-Journal of the National Comprehensive Cancer Network that finds that people diagnosed with an aggressive breast cancer subtype (HR-negative, HER2-positive) are more likely to live longer in states that participate in Medicaid expansion under the Affordable Care Act (ACA).
NCCN announces a renewed collaboration with LACOG to publish new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer: Brazil Edition. Additional Brazilian adaptations of NCCN Guidelines for other cancer types are planned for the future.
The National Comprehensive Cancer Network (NCCN) and the NCCN Foundation announce plans to make every book in the library of NCCN Guidelines for Patients available in Spanish; with select editions available in additional languages as well.
Speakers at an NCCN Oncology Policy Summit discuss the importance of diversity, equity, and inclusion (DEI) as integral to the oncology workforce to improve cancer outcomes, and what to do about backlash.
New research just-published online by JNCCN鈥擩ournal of the National Comprehensive Cancer Network finds that for many commonly used treatment regimens targeting metastatic GI cancers, it is possible to administer 5-FU solely through continuous infusion, minus the bolus component, without negatively affecting patient outcomes.
United States-based National Comprehensive Cancer Network strengthens relationship with Chinese medical platform Medlive to broaden access to eminent oncology guidelines in China.
The National Comprehensive Cancer Network (NCCN)鈥檚 research arm achieves major milestone, showcasing years of success in fostering innovation and knowledge discovery that improves the lives of patients with cancer.
NCCN shares new data on continued high prevalence for聽cancer drug shortages in the United States. In the latest survey, carboplatin and cisplatin shortages fell to 11% and 7% respectively, but 89% of centers surveyed continue to report shortages for at least one type of systemic therapy; 75% are experiencing two or more drug shortages.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right